BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Yang-Sheng Lin, Ming-Jen Chen, Wei-Chen Lin, Yuan-Hung Wang, Chiehfeng Chen. Letter: should we delay surgery, or stop anti-TNF therapy prior to elective surgical procedures in Crohn’s disease patients receiving anti-TNF agents? Authors’ replyAlimentary Pharmacology & Therapeutics 2019; 50(8): 970 doi: 10.1111/apt.15487
2
Christopher Andrew Lamb, Nicholas A Kennedy, Tim Raine, Philip Anthony Hendy, Philip J Smith, Jimmy K Limdi, Bu’Hussain Hayee, Miranda C E Lomer, Gareth C Parkes, Christian Selinger, Kevin J Barrett, R Justin Davies, Cathy Bennett, Stuart Gittens, Malcolm G Dunlop, Omar Faiz, Aileen Fraser, Vikki Garrick, Paul D Johnston, Miles Parkes, Jeremy Sanderson, Helen Terry, Daniel R Gaya, Tariq H Iqbal, Stuart A Taylor, Melissa Smith, Matthew Brookes, Richard Hansen, A Barney Hawthorne. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adultsGut 2019; 68(Suppl 3): s1 doi: 10.1136/gutjnl-2019-318484
3
Cindy CY Law, Conor Bell, Deborah Koh, Yueyang Bao, Vipul Jairath, Neeraj Narula. Risk of postoperative infectious complications from medical therapies in inflammatory bowel diseaseCochrane Database of Systematic Reviews 2020;  doi: 10.1002/14651858.CD013256.pub2
4
W A Bemelman, Michel Adamina, Christianne Buskens, Andre DHoore, Paulo Gustavo Kotze, Tom Oresland, Yves Panis, Gianluca Samprieto, Antonino Spinelli, Hagit Tulchinsky, Janindra Warusavitarne, Oded Zmora. Evolving Role of IBD SurgeryJournal of Crohn's and Colitis 2018; 12(8): 1005 doi: 10.1093/ecco-jcc/jjy056
5
Lillias Holmes Maguire, Karim Alavi, Ranjan Sudan, Paul E. Wise, Andreas M. Kaiser, Liliana Bordeianou. Surgical Considerations in the Treatment of Small Bowel Crohn’s DiseaseJournal of Gastrointestinal Surgery 2017; 21(2): 398 doi: 10.1007/s11605-016-3330-9
6
Yang-Sheng Lin, Sheng-Wei Cheng, Yuan-Hung Wang, Kee-Hsin Chen, Ching-Ju Fang, Chiehfeng Chen. Systematic review with meta-analysis: risk of post-operative complications associated with pre-operative exposure to anti-tumour necrosis factor agents for Crohn’s diseaseAlimentary Pharmacology & Therapeutics 2019; 49(8): 966 doi: 10.1111/apt.15184
7
Daniel J Wong, Eve M Roth, Joseph D Feuerstein, Vitaliy Y Poylin. Surgery in the age of biologicsGastroenterology Report 2019; 7(2): 77 doi: 10.1093/gastro/goz004
8
Sara Gaines, Sanjiv Hyoju, Ashley J. Williamson, Jasper B. van Praagh, Olga Zaborina, David T. Rubin, John C. Alverdy, Benjamin D. Shogan, Neil Hyman. Infliximab Does Not Promote the Presence of Collagenolytic Bacteria in a Mouse Model of Colorectal AnastomosisJournal of Gastrointestinal Surgery 2020;  doi: 10.1007/s11605-019-04486-5
9
Chenjing Zhu, Xuelei Ma, Luqi Xue, Jing Xu, Qingfang Li, Yun Wang, Jing Zhang. Small intestine contrast ultrasonography for the detection and assessment of Crohn diseaseMedicine 2016; 95(31): e4235 doi: 10.1097/MD.0000000000004235
10
Serena R. Martin, Robert V. Bryant. Inflammatory Bowel Disease Nursing Manual2019; : 189 doi: 10.1007/978-3-319-75022-4_21
11
Abel Botelho Quaresma, Takayuki Yamamoto, Paulo Gustavo Kotze. Biologics and surgical outcomes in Crohn’s disease: is there a direct relationship?Therapeutic Advances in Gastroenterology 2020; 13: 175628482093173 doi: 10.1177/1756284820931738
12
Cindy C Y Law, Deborah Koh, Yueyang Bao, Vipul Jairath, Neeraj Narula. Risk of Postoperative Infectious Complications From Medical Therapies in Inflammatory Bowel Disease: A Systematic Review and Meta-AnalysisInflammatory Bowel Diseases 2020;  doi: 10.1093/ibd/izaa020
13
J.W. Baddley, F. Cantini, D. Goletti, J.J. Gómez-Reino, E. Mylonakis, R. San-Juan, M. Fernández-Ruiz, J. Torre-Cisneros. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents)Clinical Microbiology and Infection 2018; 24: S10 doi: 10.1016/j.cmi.2017.12.025
14
Takayuki Yamamoto, Fabio Vieira Teixeira, Rogerio Saad-Hossne, Paulo Gustavo Kotze, Silvio Danese . Anti-TNF and Postoperative Complications in Abdominal Crohn's Disease SurgeryCurrent Drug Targets 2019; 20(13): 1339 doi: 10.2174/1389450120666190404144048
15
Bo Shen, Aimee Blake, Karen Lasch, Michael Smyth, Fatima Bhayat. Vedolizumab use in patients with inflammatory bowel diseases undergoing surgery: clinical trials and post-marketing experienceGastroenterology Report 2019; 7(5): 322 doi: 10.1093/gastro/goz034
16
Jasmine Zanelli, Subashini Chandrapalan, Abhilasha Patel, Ramesh P. Arasaradnam. The impact of pre-operative biologic therapy on post-operative surgical outcomes in ulcerative colitis: a systematic review and meta-analysisTherapeutic Advances in Gastroenterology 2020; 13: 175628482093708 doi: 10.1177/1756284820937089
17
Takayuki Yamamoto, Takahiro Shimoyama, Satoru Umegae, Paulo Gustavo Kotze. Impact of Preoperative Nutritional Status on the Incidence Rate of Surgical Complications in Patients With Inflammatory Bowel Disease With Vs Without Preoperative Biologic TherapyClinical and Translational Gastroenterology 2019; 10(6): e00050 doi: 10.14309/ctg.0000000000000050
18
C. Shwaartz, A. C. Fields, M. Sobrero, C. M. Divino. Does bowel preparation for inflammatory bowel disease surgery matter?Colorectal Disease 2017; 19(9): 832 doi: 10.1111/codi.13693
19
Alaa El-Hussuna, Pär Myrelid, Stefan D Holubar, Paulo G Kotze, Graham Mackenzie, Gianluca Pellino, Des Winter, Justin Davies, Ionut Negoi, Perbinder Grewal, Gaetano Gallo, Kapil Sahnan, Ines Rubio-Perez, Daniel Clerc, Nicolas Demartines, James Glasbey, Miguel Regueiro, Ahmed E Sherif, Peter Neary, Francesco Pata, Mark Silverberg, Stefan Clermont, Sami A Chadi, Sameh Emile, Nicolas Buchs, Monica Millan, Ana Minaya-Bravo, Hossam Elfeki, Veronica De Simone, Mostafa Shalaby, Celestino Gutierrez, Cihan Ozen, Ali Yalçınkaya, David Rivadeneira, Alssandro Sturiale, Nuha Yassin, Antonino Spinelli, Jay Warusavitarne, Argyrios Ioannidis, Steven Wexner, Julio Mayol. Biological Treatment and the Potential Risk of Adverse Postoperative Outcome in Patients With Inflammatory Bowel Disease: An Open-Source Expert Panel Review of the Current Literature and Future PerspectivesCrohn's & Colitis 360 2019; 1(3) doi: 10.1093/crocol/otz021
20
Yi Li, Weiming Zhu. Interventional Inflammatory Bowel Disease: Endoscopic Management and Treatment of Complications2018; : 273 doi: 10.1016/B978-0-12-811388-2.00024-5
21
Ana Gutiérrez, Montserrat Rivero, Maria Dolores Martín-Arranz, Valle García Sánchez, Manuel Castro, Jesús Barrio, Ruth de Francisco, Manuel Barreiro-de Acosta, Berta Juliá, Luis Cea-Calvo, Cristina Romero, Natalia Borruel Sainz, Eugeni Domènech. Perioperative management and early complications after intestinal resection with ileocolonic anastomosis in Crohn’s disease: analysis from the PRACTICROHN studyGastroenterology Report 2019; 7(3): 168 doi: 10.1093/gastro/goz010